The makers of the anti-clotting medication Xarelto were cited for allegedly misleading the editors of the New England Journal of Medicine (NEJM) by failing to include critical laboratory data. Concerns about this letter are deeply troubling for consumers who deserve transparency and full disclosure from drug makers.This article highlights a New York Times piece that raises new questions about the FDA approval process for Xarelto in 2011. The drug was approved after a fast-track regulatory review, despite the fact that some of the agencyâs own scientists had concerns about its safety.Berman & Simmons attorney Susan Faunce is working in collaboration with other national law firms to handle legal claims involving clients who took Xarelto and suffered harm.
Berman & Simmons Blog Posts
-
-
Patient safety news: $72M jury verdict links talcum powder with cancer
The use of baby powder has been linked to cancer, as a jury in St. Louis awarded $72 million to the estate of a woman who died of ovarian cancer in 2015.Lawyers had alleged that use of manufacturer Johnson & Johnsons powder products over a 30-year period had caused inflammation and cancer to their clients ovaries. They claimed the manufacturer knew about a correlation between talcum powder and cancer, but did nothing to alert the public to potential health risks.This article details results of the lawsuit, and offers links to more information.Berman & Simmons attorney Susan Faunce is working in collaboration with other national law firms to handle legal claims involving women who developed ovarian cancer after use of products containing talc.
-
Patient Safety News: IVC filter maker knew about risks, failed to act, report says
Serious questions have been raised about why the manufacturer of a popular blood-clot filter did not remove its dangerous product from the marketplace.According NBC, manufacturer C.R. Bard knew about safety risks with its G2 series IVC filters around the time of their FDA approval in 2005 but continued to market them until 2010. The filters have since been linked to at least 12 deaths and hundreds of injuries.This article gives more information about NBCs reporting.Berman & Simmons attorney Michael Bigos is working in collaboration with other national law firms to handle legal claims involving patients who developed harmful complications due to the use of G2 and other types of IVC filters.
-
Patient Safety News: One doctors fight against power morcellation
Married doctors in Philadelphia recently shared their intensely personal story about fighting cancer, which they believe was spread by a power morcellator, a device that until recently had been commonly used during gynecological surgeries.This article highlights Dr. Amy Reed and her husband, as reported in the Philadelphia Inquirer. Reed was diagnosed with leiomyosarcoma cancer in 2013 after what was planned to be a routine hysterectomy. The post includes a video and more information.Berman & Simmons attorney Susan Faunce is working in collaboration with other national law firms to handle legal claims involving women diagnosed with cancer after a gynecological surgery involving morcellation.
-
Patient Safety News: Zofran linked to congenital heart defect
The anti-nausea drug Zofran continues to be in the public spotlight because of claims that it can cause birth defects, including cleft lip and palate, if used by expecting mothers.The controversy was the focus of a report recently by the Fox TV affiliate in Boston, where many Zofran lawsuits have been consolidated in federal court against drug maker GlaxoSmithKline. This article links to media coverage about Beth Botelho, who used Zofran during pregnancy, and her daughter Marissa, who was born needing heart surgery.Berman & Simmons attorney Susan Faunce is working in collaboration with other national law firms to handle legal claims involving women who took Zofran and whose unborn children suffered injuries or birth defects.
-
Welcome to the Berman & Simmons Blog!
Read personal-injury related articles that matter to you. We will provide trustworthy, in-depth, common sense information and advice about legal problems that real people face in Maine, New England, and beyond.